Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
NCT: NCT07293871 · RECRUITING
Brief Summary
This two-stage, multicenter clinical trial is designed to evaluate the feasibility, safety, and preliminary efficacy of splenic ultrasound stimulation to activate immune-neuromodulation (SUSTAIN) in patients with rheumatoid arthritis (RA) and at least moderate disease activity. The findings from this trial will directly inform the design and power calculations for a future pivotal trial by identifying an appropriate effect size and confirming protocol feasibility and safety.
Frequently Asked Questions
What is Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis?
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis is a clinical trial registered under NCT07293871. Current status: RECRUITING.
What is the status of NCT07293871?
The current status of NCT07293871 (Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis) is: RECRUITING.
When did Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis start?
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis started on 2026-03-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.